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Human metapneumovirus (HMPV) inclusion bodies (IBs) are dynamic structures required for efﬁcient viral replication and transcription. The minimum components
needed to form IB-like structures in cells are the nucleoprotein (N) and the tetrameric
phosphoprotein (P). HMPV P binds to the following two versions of the N protein in
infected cells: N-terminal P residues interact with monomeric N (N0) to maintain a pool
of protein to encapsidate new RNA and C-terminal P residues interact with oligomeric,
RNA-bound N (N-RNA). Recent work on other negative-strand viruses has suggested
that IBs are, at least in part, liquid-like phase-separated membraneless organelles. Here,
HMPV IBs in infected or transfected cells were shown to possess liquid organelle properties, such as fusion and ﬁssion. Recombinant versions of HMPV N and P proteins were
puriﬁed to analyze the interactions required to drive phase separation in vitro. Puriﬁed
HMPV P was shown to form liquid droplets in isolation. This observation is distinct from
other viral systems that also form IBs. Partial removal of nucleic acid from puriﬁed P
altered phase-separation dynamics, suggesting that nucleic acid interactions play a role
in IB formation. HMPV P also recruits monomeric N (N0-P) and N-RNA to droplets in
vitro. These ﬁndings suggest that HMPV P may also act as a scaffold protein to mediate
multivalent interactions with monomeric and oligomeric N, as well as RNA, to promote
phase separation of IBs. Together, these ﬁndings highlight an additional layer of regulation in HMPV replication by the viral P and N proteins.
IMPORTANCE Human metapneumovirus (HMPV) is a leading cause of respiratory disease among children, immunocompromised individuals, and the elderly. Currently,
no vaccines or antivirals are available for the treatment of HMPV infections.
Cytoplasmic inclusion bodies (IBs), where HMPV replication and transcription occur,
represent a promising target for the development of novel antivirals. The HMPV
nucleoprotein (N) and phosphoprotein (P) are the minimal components needed for
IB formation in eukaryotic cells. However, interactions that regulate the formation
of these dynamic structures are poorly understood. Here, we showed that HMPV
IBs possess the properties of liquid organelles and that puriﬁed HMPV P phase separates independently in vitro. Our work suggests that HMPV P phase-separation dynamics are altered by nucleic acid. We provide strong evidence that, unlike results
reported from other viral systems, HMPV P alone can serve as a scaffold for multivalent interactions with monomeric (N0) and oligomeric (N-RNA) HMPV N for IB
formation.
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HMPV P-Promoted Phase Separation

mBio

uman metapneumovirus (HMPV), discovered in 2001, is a leading cause of severe
respiratory tract infections in infants, the elderly, and immunocompromised individuals (1). A total of 5% to 20% of hospitalizations from respiratory infections in young
children are due to HMPV (2, 3). Symptoms of HMPV infection are similar to respiratory
syncytial virus (RSV) and include fever, cough, rhinorrhea, croup, bronchiolitis, pneumonia, and asthma exacerbation (4). HMPV and RSV are members of the
Pneumoviridae family, a viral family that was created in 2016 and classiﬁed within the
Mononegavirales order (5). Currently, no vaccines or antiviral treatments are approved
to treat HMPV infections, so most patients are managed with supportive care (4). The
recent discovery of HMPV highlights the need to understand the basic mechanisms of
its life cycle. Speciﬁcally, analyzing the process of HMPV replication may be crucial for
identifying new targets for antiviral development.
Along with the pneumoviruses HMPV and RSV, other relevant human pathogens
within the Mononegavirales order include Ebola virus, measles virus (MeV), and rabies
virus (RABV), which have negative-sense, single-stranded RNA genomes. Although
these viruses are classiﬁed within different families, they have all been reported to
form membraneless cytoplasmic structures within infected cells known as inclusion
bodies (IBs) (6–9). For some negative-sense, single-stranded RNA viruses, including
HMPV, IBs have been shown to house active viral replication and transcription (10–17).
These processes involve several viral proteins, such as the large RNA-dependent RNApolymerase (L), phosphoprotein (P), and nucleoprotein (N). Further analysis of these
structures has shown that RSV, MeV, RABV, and vesicular stomatitis virus (VSV) IBs possess the properties of liquid organelles formed via phase separation (15, 18–21). Phase
separation is a physical process by which a homogenous ﬂuid separates into two distinct liquid phases (22). Phase separation plays a role in the formation of a variety of
membraneless cellular compartments, such as processing bodies (P-bodies), stress
granules, and nucleoli, to concentrate speciﬁc proteins and nucleic acids, particularly
RNA (23). Properties that deﬁne these structures as liquid organelles include the ability
to undergo fusion and ﬁssion, rapid diffusion of internal contents, and a spherical
shape due to surface tension (24). Although phase separation has been shown to play
a role in the formation of IBs for some viruses, the physical mechanisms and materials
that mediate this process in the viral life cycle are still poorly understood.
For RSV, HMPV, MeV, and RABV, the minimum viral components required to reconstitute IB-like structures in cells are the N protein, which encapsidates the RNA genome, and the P protein, which acts as a cofactor to mediate interactions between N
and L (15, 19, 25, 26). VSV also requires the presence of the L protein with the N and P
proteins to form IBs (18). These ﬁndings suggest that interactions between the N and P
proteins regulate phase separation to form IBs as a structural platform for viral replication and transcription. Most studies thus far have focused on cellular experiments to
investigate viral IB liquid dynamics, but recent publications on MeV and RSV have
shown the importance of utilizing puriﬁed protein systems to analyze interactions
between the N and P proteins in vitro (20, 21). For MeV, the recombinant Escherichia
coli-expressed and puriﬁed P and monomeric N proteins failed to phase separate independently, but they formed liquid droplets when mixed, similar to the requirements for
IB formation observed in cells. Interestingly, when RNA was added to MeV N/P liquid
droplets, it was incorporated into the droplets and led to the formation of nucleocapsidlike particles that were detected by electron microscopy (20). In vitro experiments with
recombinant E. coli-expressed RSV proteins showed that RNA-bound N protein rings and
P protein form phase-separated liquid droplets when combined in solution (21). These
ﬁndings support the model that viral IBs form via phase separation, and this mechanism
is highly dependent upon interactions between the N and P proteins. This process may
enhance viral replication and transcription for RSV.
The HMPV life cycle begins with the virus attaching and fusing to a target cell to
release its ribonucleoprotein into the cytoplasm. The ribonucleoprotein structure protects the genome from host nucleases and detection by host pattern recognition
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receptors and acts as a template for the L protein. The genome is used to generate
capped and polyadenylated viral mRNA transcripts that are translated by the host cell
ribosomal machinery. The genome is also replicated to make positive-sense antigenome copies that can then be used to generate more negative-sense genome to package into new virions.
The P protein acts as an adaptor to regulate interactions between the polymerase
and RNA template during transcription and replication. It functions as a tetrameric protein, in which the monomers interact through a central oligomerization domain (27,
28). The oligomerization domain is ﬂanked by large intrinsically disordered regions
(IDRs) that give HMPV P the ability to interact with a variety of binding partners (27).
For instance, the C terminus of the P protein interacts with RNA-bound N protein to
chaperone attachment to the polymerase. Additionally, HMPV P maintains a monomeric pool of RNA-free N protein (N0) through an interaction involving the HMPV P N
terminus with the C-terminal domain of the N protein (29). The monomeric N0 protein
can then be used for ribonucleoprotein assembly at sites of replication where the polymerase synthesizes nascent RNA (29). HMPV P also recruits the antitermination factor
M2-1 to the polymerase during transcription to bind nascent viral mRNA (30). A structural analysis of the HMPV polymerase/P protein complex showed the versatility of P
monomer interactions with the polymerase, suggesting that IDRs in the P protein modulate a variety of polymerase functions as well (31). Beyond transcription and replication, HMPV P has been shown to play a role in direct cell-to-cell spread of infection by
interacting with actin, or an actin-binding protein, to reorganize the host cell cytoskeleton (32).
This is the ﬁrst report to analyze phase separation for HMPV IBs. We utilized cellular
and puriﬁed protein systems to analyze phase separation of HMPV proteins to support
the characterization of HMPV IBs as liquid organelles and to determine the interactions
required for phase separation. We report that HMPV IBs are liquid-like membraneless
structures that rely on N/P protein interactions. Our in vitro data show that HMPV N
and P undergo phase separation and colocalize within liquid droplets when they are
mixed in solution. In contrast to MeV and RSV, the HMPV P protein undergoes phase
separation in the absence of other viral protein binding partners in vitro, suggesting
that the P protein may be the key protein to mediate protein interactions to promote
IB formation during infection. Wild-type (WT) RNA-bound N protein rings formed
aggregates in solution but incorporated into liquid droplets in the presence of the P
protein. These ﬁndings suggest for the ﬁrst time that HMPV P acts as a scaffold protein
to support multivalent interactions with HMPV N to promote phase separation and IB
formation.
RESULTS
HMPV P localizes to liquid-like IBs in transfected and infected cells. During HMPV
infection, incoming and newly synthesized ribonucleoproteins concentrate together in
the cytoplasm in an actin-dependent manner (11, 33). Eventually, the coalescence of
these structures induces the formation of IBs where viral RNA, viral mRNA, P protein,
and N protein are detected (11). Inhibition of actin polymerization signiﬁcantly reduces
HMPV genome transcription and replication, suggesting that IB coalescence enhances
the efﬁciency of these processes (11). To gain insights into IB dynamics in HMPVinfected cells, we generated a recombinant virus with an N terminus mCherry-tagged
P protein. mCherry-P retained at least 60% of activity in minireplicon assays, while tagging P on its C terminus resulted in deleterious effects (data not shown). To characterize the growth kinetics of the recombinant HMPV-mCherryP virus, Vero cells were
infected at a multiplicity of infection (MOI) of 0.1 PFU/cell. Infected cells were maintained in the presence (TPCK1) or absence (TPCK2) of trypsin until 16 days postinfection. Viral titers from supernatants increased until day 10, after which virus growth
reached a plateau (Fig. 1A). As expected, HMPV did not grow efﬁciently in the absence
of TPCK trypsin (Fig. 1A). Viral titers for the recombinant HMPV-mCherryP virus were
May/June 2022 Volume 13 Issue 3

10.1128/mbio.01099-22

3

Downloaded from https://journals.asm.org/journal/mbio on 05 July 2022 by 128.252.154.28.

HMPV P-Promoted Phase Separation

mBio

FIG 1 Characterization of a recombinant HMPV-mCherryP virus. (A) Vero cells were infected with an MOI of 0.1, and cells were kept in the absence
(TPCK2) or presence (TPCK1) of trypsin until day 16 postinfection. Virus was harvested from the cell supernatants every other day and titrated. Vero cells
were infected with HMPV-mCherryP virus using an MOI of 3 to quantify the number of IBs per cell (B) and IB diameter (C) at different times postinfection.
Fusion (D) and ﬁssion (E) events were counted in Vero cells infected with HMPV-mCherryP at an MOI of 3, during a lapse of 10 min. Images were acquired
every 30 sec using a LionHeartFX ﬂuorescence microscope. (F) Time-lapse microscopy of Vero cells infected with HMPV-mCherryP, highlighting ﬁssion
events (top; yellow arrowheads) and fusion events (bottom; white arrowheads). (G) Vero cells were electroporated with a plasmid encoding mCherryP and
subsequently infected with rgHMPV-GFP virus. Forty-eight hours postinfection time-lapse microscopy was performed using a NikonA1 confocal microscope,
with images acquired every 25 sec. Fusion (white arrowheads) and ﬁssion (yellow arrowheads) events are shown. Statistical analysis was performed using
Student’s t test. *, P , 0.1; **, P , 0.01.

slightly lower than those reported previously for the recombinant JPS02-76EGFP virus
(34), but this ﬁnding was expected since the mCherryP protein did not retain full replicative activity. It was shown previously that IBs coalesce to a small number of larger
structures over the early part of infection and that this process correlates with maximization of replication efﬁciency (11). In agreement with this result, low numbers of IBs
were detected in HMPV-mCherryP infected cells at 24 to 72 h postinfection (hpi)
(Fig. 1B). In addition, the size of IBs was shown to nearly double, from 2 m m to almost
4 m m, from 24 to 72 hpi (Fig. 1C), suggesting a maturation of IBs and potentially
increased replication during this period. Using live-cell imaging, frequent events of
fusion and ﬁssion between IBs were observed (Fig. 1D to F). The frequency of ﬁssion
events per cell increased signiﬁcantly from 24 to 72 hpi (Fig. 1E), coinciding with the
increase in size observed at these hpi. Additionally, incorporation of mCherryP into IBs
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FIG 2 FRAP analysis of HMPV P protein in inclusion bodies and the cytosol. (A) Vero cells were
transfected with pCAGGS plasmid expressing mCherry-P only (P) or cotransfected with pCAGGS
plasmids encoding mCherry-P and N protein (P1N). At 24 h posttransfection, live-cell confocal
microscopy was used to perform FRAP at 37°C on punctate regions by drawing a region of interest
(ROI) representing a whole inclusion body or an equivalent area in the cytosol with P protein only.
FRAP data were corrected for background, were normalized, and are represented as means from the
recovery curves. (B) Live-cell confocal images collected during FRAP, showing recovery proﬁles of
inclusions 4 min postbleaching. Bleaching was performed at 100% laser power.

was observed in mCherryP electroporated-rgHMPV-infected cells (Fig. 1G). Fusion and
ﬁssion events of the IBs in these transfected-infected cells was observed using live-cell
imaging, suggesting that HMPV P has an inherent propensity to be incorporated into
IBs. Altogether, our results suggest that as infection progress, HMPV IBs grow and
increase in complexity and dynamic behavior.
The liquid-like nature of HMPV IB-like structures was analyzed in transfected cells using
ﬂuorescence recovery after photobleaching (FRAP) to compare ﬂuorescence recovery
rates. When cells were transfected with HMPV P alone, the P protein showed diffuse cytosolic localization and rapid ﬂuorescence recovery (Fig. 2). Alternatively, when cells were
transfected with both HMPV N and P to induce IB-like structure formation, HMPV P
ﬂuorescence recovery rates in the region of the IB were reduced but recovery was
still observed, consistent with what is expected for membraneless liquid-like organelles. This result suggests that interactions between HMPV N and P lead to changes
in cellular protein dynamics to form phase-separated regions. Together, these
results support the characterization of HMPV IBs as liquid organelles formed by
phase separation as sites for efﬁcient replication and transcription.
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Isolated HMPV P phase separates in vitro. Because HMPV N and P proteins are
the minimum requirements for IB-like structure formation in eukaryotic cells, recombinant versions of the proteins were expressed in E. coli and puriﬁed for in vitro analysis.
Puriﬁed HMPV P was tested in the presence of the crowding agent dextran, used to
mimic cytosolic crowding conditions, to assess its ability to undergo phase separation
(24). Phase separation is driven typically by scaffold proteins with speciﬁc features that
promote multivalent interactions with other proteins or RNA (35–37). HMPV P, which
includes long IDRs and alternating charged regions, ﬁts the criteria of a phase separation scaffold protein (27). Unlike the reports for E. coli-expressed MeV and RSV proteins,
puriﬁed HMPV P formed liquid droplets in the absence of N that were visualized using
differential interference contrast (DIC) microscopy, and droplet formation was dependent on the concentration of the P protein (Fig. 3A). Some variation in droplet size was
observed at each concentration, potentially due to factors that can affect droplet dynamics, such as local protein or RNA concentration (24).
Time lapse imaging of the HMPV P droplets showed that they underwent fusion,
consistent with the idea that they possess a liquid nature (Fig. 3B). A turbidity assay
was also used to analyze puriﬁed HMPV P phase separation. The absorbance of the
puriﬁed HMPV P protein solution was measured at 395 nm at different time points to
detect phase separation. The measurements showed a peak for the absorbance above
0.12 between 2 and 4 h, supporting the microscopy imaging results that HMPV P phase
separates in the absence of other viral protein binding partners (Fig. 3C). Dextran
buffer alone or puriﬁed green ﬂuorescent protein (GFP) in the presence of the dextrancontaining buffer was examined (see Fig. S3 in the supplemental material), but no GFP
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FIG 3 Anion exchange-puriﬁed HMPV P phase separates independently in vitro. (A) Anion exchangepuriﬁed HMPV P was tested at concentrations ranging from 5 m M to 50 m M in a droplet assay
(maximum droplet size, 3.4 m m). DIC microscopy imaging of droplets was performed with a 60
objective on a Nikon Eclipse E600 microscope. The scale bar is 10 m m. (B) Time lapse imaging of
anion exchange puriﬁed HMPV P (80 m M) droplet fusion was acquired using a 100 oil objective on
a Zeiss Axiovert 200M microscope. Scale bar, 5 m m. (C) Anion exchange-puriﬁed HMPV P (40 m M) was
mixed with turbidity assay buffer in a clear 96-well plate. The solution was analyzed using a
SpectraMax iD3 instrument to measure the absorbance at 395 nm at 5-min intervals with mixing.

mBio

FIG 4 RSV phosphoprotein alone is unable to undergo liquid-liquid phase separation. (A) HMPV P protein was tested parallel
with puriﬁed RSV A2 P protein, using the same dextran buffer used to mimic the cytosol. RSV P is unable to undergo liquid-liquid
phase separation in this study. Droplet assays were performed side by side. DIC microscopy was performed on the Axiovert 200M
instrument with a 63 oil objective; scale bar, 10 m m. (B) A schematic of the HMPV P protein amino acid sequence, with
representation of residue insertions within HMPV (blue), compared with RSV P, and RSV P insertions (gray), compared with HMPV
P. HMPV P (HMPV; Uniprot Q8B9Q8) and RSV (RSV A2; Uniprot P03421) sequences were acquired through the Uniprot database
and aligned using the NCBI alignment tool, with adjustments made based on observations in Cardone et al. (45). Made with
BioRender.com.

droplet formation was observed, consistent with previous work indicating that GFPtags can be appended to proteins without affecting phase separation character (38),
and that phase separation is not a general characteristic of proteins in the presence of
the buffer. Finally, E. coli-expressed and -puriﬁed RSV P was tested under the same conditions in a droplet assay side by side with HMPV P. No droplet formation was observed
for RSV P when it was tested in isolation (Fig. 4A), consistent with other work on RSV P
in vitro droplet formation (22), but HMPV P tested at the same time again showed
droplet formation, indicating a key difference between HMPV and RSV P.
Interactions with nucleic acid modulate HMPV P phase separation dynamics.
Using the protein puriﬁcation protocol described above, we noticed that the A260/280 ratio was approximately 1.08, suggesting that the HMPV P protein sample contained
nucleic acid. Since nucleic acids are known to play a role in phase separation, we utilized an alternative puriﬁcation protocol to determine if removing the nucleic acid
May/June 2022 Volume 13 Issue 3
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would inﬂuence HMPV P liquid droplet formation. The alternative protocol included
treatment with Benzonase nuclease and an immobilized metal afﬁnity chromatography
(IMAC) puriﬁcation step followed by a heparin afﬁnity column puriﬁcation. This method
was successful in removing some of the nucleic acid, as indicated by the decreased
A260/280 ratio of 0.85. Interestingly, the DIC microscopy analysis showed that the
recombinant HMPV P protein puriﬁed by our alternative protocol formed larger liquid
droplets than the original protein sample (Fig. 5A). In addition, time-lapse imaging
analysis showed that the liquid droplets were capable of fusing (Fig. 5B). Turbidity
assay results for the heparin-puriﬁed HMPV P protein were similar to those for previous
samples, with a peak above 0.12 between 2 and 4 h (Fig. 5C). These results suggest
that the presence of increased levels of nucleic acid modulate HMPV P phase separation dynamics. Charge interactions are known to inﬂuence phase separation and
nucleic acid binding, so both versions of puriﬁed HMPV P (anion exchange puriﬁed
and heparin puriﬁed) were analyzed for liquid droplet formation using buffers with different concentrations of potassium chloride (KCl) ranging from 0 to 500 mM. For the
anion exchange-puriﬁed HMPV P, liquid droplets were detected easily between 150
and 250 mM KCl. However, droplet formation was inhibited at concentrations below or
above that range (Fig. 6). In contrast, the heparin-puriﬁed P protein was able to form
droplets with as little as 100 mM KCl and as much as 500 mM KCl (Fig. 6). For the heparin-puriﬁed HMPV P, the largest droplets formed at a 150 mM KCl droplet size ranging
from 0.5 to 5 m m, with an average of 0.64 m m. Average IB size was lower, comparatively, in 250 mM salt (average droplet size of 2.5 m m), and similar results were
observed at the 500 mM concentration. The anion-exchanged protein also formed the
largest droplets at the 150 mM concentration with an average size of 2.36 m m ranging
from 0.57 m m to 6.8 m m. The anion-puriﬁed P protein also formed smaller droplets
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FIG 5 Heparin-puriﬁed HMPV P phase separates independently in vitro. Heparin-puriﬁed HMPV P was
tested at concentrations ranging from 5 m M to 50 m M in a droplet assay (maximum droplet size,
.50 m m). DIC microscopy imaging of droplets was performed with a 60 objective on a Nikon
Eclipse E600 microscope. Scale bar, 10 m m. (B) Time-lapse imaging of heparin-puriﬁed HMPV P (150
m M) droplet fusion was acquired using a 100 oil objective on a Zeiss Axiovert 200M microscope.
Scale bar, 5 m m. (C) Heparin-puriﬁed HMPV P (40 m M) was mixed with turbidity assay buffer in a clear
96-well plate. The solution was analyzed using a SpectraMax iD3 instrument to measure the
absorbance at 395 nm at 5-min intervals with mixing.
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with increasing salt concentration above 150 mM, with an average diameter of 1.7 m m
at 250 mM KCl and 1 m m at 300 mM KCl. Droplets were consistently smaller for the
anion exchange-puriﬁed protein in contrast to the heparin-puriﬁed product at comparable salt concentrations. These results suggest that HMPV P protein samples containing higher levels of nucleic acid are more sensitive to changes in charge, thus leading
to the disruption of liquid droplet formation in vitro.
HMPV P recruits N0-P to liquid droplets. WT HMPV N spontaneously oligomerizes
and binds to nonspeciﬁc RNAs during standard puriﬁcation procedures (29). Thus, we
utilized a recombinant N0-P construct that includes full-length N (1 to 394) fused to a P
peptide (1 to 40) to maintain N in a monomeric, RNA-free form for puriﬁed protein
analysis (Fig. 7A), a strategy that had been successfully utilized by Renner et al. (29).
The N0-P construct puriﬁed by IMAC formed gel-like structures that clumped together
in irregular shapes that were visualized by DIC microscopy (Fig. 7B). Unlike anion
exchange-puriﬁed HMPV P, the gel-like HMPV N0-P structures remained partially undissolved in 500 mM KCl (data not shown). Over time, these gel-like structures aggregated
together but did not undergo fusion (Fig. 7B). In agreement with our microscopy
results, turbidity assays performed with the IMAC-puriﬁed N0-P protein gave high absorbance readings that peaked above 0.6, further indicating that the gel-like structures
were aggregating in solution (Fig. 7E). The subsequent drop in absorbance suggests
that the aggregates settled to the bottom of the 96-well plate.
The N0-P construct was examined in combination with anion exchange-puriﬁed
HMPV P using a droplet assay to determine if the P protein could inﬂuence N0-P dynamics in solution. DIC and ﬂuorescence microscopy analyses showed that mixing the
two proteins led to enhanced phase separation as indicated by the presence of larger
and more numerous droplets than we observed previously for HMPV P alone. N0-P and P
were incorporated into the same liquid droplets, as indicated by the colocalization of the
ﬂuorescent signals used to label the proteins (Fig. 7C). In addition, the phase-separated
droplets underwent fusion events (Fig. 7D). A turbidity assay was utilized to determine if
combining N0-P with P affected the absorbance of the solution. The results showed that
compared with N0-P alone, the combination of N0-P and P led to lower absorbance readings that peaked around 0.3 at 2 h (Fig. 7E). Together, these ﬁndings support that HMPV
P facilitates interactions with N0-P to recruit the protein into liquid droplets and interactions between the proteins prevent the N0-P construct from transitioning to a gel-like
state.
HMPV P recruits N-RNA rings to liquid droplets. In addition to the monomeric
N0-P construct, WT N-RNA rings were puriﬁed for phase separation analysis in the presence or absence of HMPV P. DIC imaging of N-RNA rings in the droplet assay showed
May/June 2022 Volume 13 Issue 3
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FIG 6 The presence of nucleic acid modulates HMPV P phase-separation dynamics. Anion exchangepuriﬁed HMPV P (15 m M) and heparin-puriﬁed HMPV P (15 m M) were tested in a droplet assay using
buffers with different concentrations of KCl ranging from 0 mM to 500 mM. The DIC microscopy
imaging of droplets was performed with a 60 objective on a Nikon Eclipse E600 microscope. Scale
bar, 10 m m; the magniﬁcation is the same for all images.
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the formation of clumped, irregularly shaped structures that did not undergo fusion,
suggesting that this protein-RNA complex does not form liquid-like phase-separated
structures independently (Fig. 8A). Combining the puriﬁed N-RNA rings with heparinpuriﬁed HMPV P resulted in N-RNA complex incorporation into liquid droplets (Fig. 8B).
The N-RNA/P droplets (maximum droplet size, 6 m m) were generally smaller than the P
alone droplets (maximum droplet size, 11 m m), suggesting that this combination inﬂuences phase separation dynamics. The inﬂuence of HMPV P on N-RNA for liquid droplet
formation was reﬂected in the turbidity assay results which showed a lower peak for
absorbance around 0.2 at 2 h than the absorbance for N-RNA alone (Fig. 8D).
HMPV P and N-RNA were tested in our in vitro system at different ratios to determine the conditions that were required for N-RNA to be recruited to liquid droplets.
Although N-RNA aggregates were still present at 4:1 and 2:1 ratios of N-RNA/P, round
droplets were detected easily at a 1:1 ratio. The number and size of the round droplets
increased in samples with a higher proportion of HMPV P (1:2 and 1:4) (Fig. 8C). These
results suggest that a speciﬁc ratio of N-RNA/P must be met before N-RNA is induced
to phase separate into droplets. Liquid droplets containing HMPV P and N-RNA were
also shown to incorporate a ﬂuorescent RNA oligomer (Fig. 7E). These ﬁndings highlight that HMPV P, N, and RNA form complex multivalent interactions to promote
phase separation and to support the structure of IBs required to enhance replication
and transcription.
HMPV P recruits RNA-binding mutant N K171A/R186A to gel-like droplets. An
HMPV N mutant (K171A/R186A) was generated to determine if RNA binding affects
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FIG 7 HMPV P recruits N0-P to liquid droplets. (A) Schematic of the N0-P construct which includes
full-length HMPV N fused to the ﬁrst 40 amino acids of HMPV P. (B) HMPV N0-P (15 m M) was tested
in a droplet assay. DIC images were acquired at different time points using a 60 objective on a
Nikon Eclipse E600 instrument. Scale bar, 7 m m. (C) HMPV N0-P (15 m M) labeled with Alexa 488 TFP
ester was mixed with anion exchange-puriﬁed HMPV P (15 m M) labeled with Alexa 594 NHS ester in a
droplet assay. Fluorescence images were acquired using a 60 objective on a Nikon Eclipse E600
instrument. Scale bar, 10 m m. (D) HMPV N0-P (50 m M) was mixed with anion exchange-puriﬁed HMPV
P (50 m M). Time-lapse imaging of N0-P/P droplet fusion was acquired using a 100 oil objective on a
Zeiss Axiovert 200M microscope. Scale bar, 10 m m. (E) HMPV N0-P (40 m M) was tested alone or with
anion exchange-puriﬁed HMPV P (40 m M) in a turbidity assay. The protein solutions were plated in a
clear 96-well plate with turbidity assay buffer, and the absorbance was measured at 395 nm by a
SpectraMax iD3 instrument at 5-min intervals.

mBio

FIG 8 HMPV P recruits N-RNA rings to liquid droplets. (A) HMPV N-RNA (25 m M) was tested in a
droplet assay. The DIC microscopy imaging of droplets was performed with a 60 objective on a
Nikon Eclipse E600 microscope. Scale bar, 10 m m. (B) HMPV N-RNA (15 m M) was mixed with heparinpuriﬁed HMPV P (15 m M) in a droplet assay. DIC images were acquired using a 60 objective on a
Nikon Eclipse E600 instrument. Scale bar, 10 m m. (C) HMPV N-RNA and heparin-puriﬁed HMPV P were
tested in a droplet assay at different ratios (4:1 for 20 m M N-RNA: 5 m M P; 2:1 for 10 m M N-RNA:
5 m M P; 1:1 for 5 m M N-RNA: 5 m M P; 1:2 for 5 m M N-RNA: 10 m M P; 1:4 for 5 m M N-RNA: 20 m M P).
The DIC microscopy imaging of droplets was performed as described above. (D) HMPV N-RNA
(40 m M) was tested alone or with heparin-puriﬁed HMPV P (40 m M) in a turbidity assay. The protein
solutions were plated in a clear 96-well plate with turbidity assay buffer, and the absorbance was
measured at 395 nm by a SpectraMax iD3 instrument at 5-min intervals with mixing. (E) HMPV N-RNA
(15 m M), heparin-puriﬁed HMPV P (15 m M) and an RNA decamer tagged with 6-carboxyﬂuorescein on
the 39 end (5 m M) were mixed and tested in a droplet assay. The DIC and ﬂuorescence microscopy
imaging of droplets were performed as described above. Scale bar, 10 m m.

N recruitment into droplets. This mutant was designed based on the RSV construct
N K170A/R185A which lacks the ability to bind RNA (39). HMPV N0-P, N-RNA, and N
K171A/R186A were tested individually with a ﬂuorescent RNA oligomer in a droplet
assay to assess the RNA-binding capabilities of the different constructs. The RNA
oligomer incorporated into N0-P structures, suggesting that the RNA may disrupt
binding of the P1-40 peptide to N (Fig. 9A). Alternatively, the P1-40 peptide, which contains positively charged residues, may interact directly with the RNA oligomer. In
contrast to N0-P, N-RNA showed a weak interaction with the ﬂuorescent RNA
oligomer, suggesting that the oligomer poorly disrupts the existing interactions
between HMPV N and RNA in stable ring structures (Fig. 9A). The N K171A/R186A
mutant showed no colocalization with the ﬂuorescent RNA oligomer, suggesting
that the mutation of these residues in the RNA-binding cleft of HMPV N effectively
inhibits RNA binding or signiﬁcantly slows the exchange between any bound RNA
and the ﬂuorescent RNA oligomer (Fig. 9A).
Subsequently, HMPV N K171A/R186A was tested at different ratios with heparinpuriﬁed HMPV P in a droplet assay to analyze phase-separation dynamics (Fig. 9B). At a
4:1 ratio of N K171A/R186A:P, microscopy imaging showed the presence of aggregates
and no liquid droplets. Droplets became visible as the concentration of HMPV P was
increased relative to the N RNA-binding mutant. However, the droplets exhibited gelMay/June 2022 Volume 13 Issue 3
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like features, and droplets were seen to adhere to each other (Fig. 8A) but were unable
to undergo fusion. This ﬁnding suggests that RNA binding to HMPV N or the presence
of charged surfaces due to the presence of RNA plays an important role in modulating
phase-separation dynamics in vitro and supports our model that HMPV P, N, and RNA
form complex interactions in cells to promote replication and transcription.
DISCUSSION
IB formation has been reported for many negative-strand viruses across the
Mononegavirales order (40). Recent evidence supports that these structures function as
viral factories by concentrating the materials required for replication and transcription.
Cellular studies of IBs have shown that these structures are membraneless and
dynamic, which led to the characterization of IBs as liquid organelles. Although membraneless organelles have been recognized in the cell for decades, the formation of
these structures has been linked only recently to the process of phase separation.
Understanding the role of phase separation in IB formation may be critical for discovering new targets for pan-antiviral development. Until now, no reports have been published to determine if HMPV IBs are consistent with phase-separated liquid organelles.
In this study, cellular experiments were utilized to analyze the dynamic nature of HMPV
IBs in infected or transfected cells. Additionally, in vitro experiments were performed to
test recombinant versions of HMPV, E. coli-expressed, puriﬁed proteins in phase-separation
assays. These studies provide strong evidence for the novel role of HMPV P as a scaffold
for recruiting N protein, and other components, to phase-separated regions.
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FIG 9 RNA-binding mutant HMPV N K171A/R186A forms gel-like droplets with P. (A) HMPV N0-P, NRNA, or N K171A/R186A (15 m M) were tested in a droplet assay with an RNA decamer tagged with 6carboxyﬂuorescein on the 39 end (5 m M). DIC and ﬂuorescence microscopy imaging were performed
on a Zeiss Axiovert 200M instrument with a 63 oil objective. Scale bar, 10 m m. (B) HMPV N K171A/
R186A and heparin-puriﬁed HMPV P were tested in a droplet assay at different ratios (4:1 for 20 m M
N K171A/R186A: 5 m M P; 2:1 for 10 m M N K171A/R186A: 5 m M P; 1:1 for 5 m M N K171A/R186A: 5 m M
P; 1:2 for 5 m M N K171A/R186A: 10 m M P; 1:4 for 5 m M N K171S/R186A: 20 m M P). The DIC
microscopy imaging of droplets was performed on a Zeiss Axiovert 200M microscope with a 63 oil
objective. White arrowheads indicate altered droplet fusion. Scale bar, 10 m m.
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Cellular analysis of HMPV IBs, using live-cell imaging and FRAP, showed that these
structures form as distinct phase-separated regions that exchange components with
the surrounding cytoplasm and undergo fusion and ﬁssion. Interestingly, our analysis
of cells infected with recombinant HMPV-mCherryP virus showed that levels of IB
fusion remained stable from 24 to 72 hpi, whereas ﬁssion events increased signiﬁcantly
during this time frame (Fig. 1). Since IB diameter increased signiﬁcantly from 24 to 72
hpi, this ﬁnding suggests that early fusion events and the incorporation of cellular
components, newly synthesized HMPV proteins, and viral RNA contribute to the
growth of IBs over time. Furthermore, the plateau of fusion events suggests that IBs
likely mature to a gel-like state by 72 hpi. In contrast, ﬁssion levels may be less affected
by the gel-like state due to the activity of vesicles that trafﬁc IB components out of
large IBs, as we have observed via live-cell imaging (data not shown). IB ﬁssion events
may be linked to the release of small replication bodies to create new viral factories
(15). Alternatively, ﬁssion may promote the formation of unique IB subpopulations
later in infection to facilitate assembly and budding (41). These ﬁndings highlight the
crucial role IBs likely play in establishing and promoting the spread of infection.
To analyze the protein interactions that govern IB formation, we compared puriﬁed
HMPV P in the presence or absence of nucleic acid with a set of N forms using in vitro
phase-separation experiments. Importantly, we found that HMPV P phase separates independently in vitro and can act as a scaffold to recruit other client proteins, including
HMPV N, to liquid droplets to drive phase separation. Additionally, our ﬁndings suggest
a previously undescribed role for HMPV P in interacting with RNA, an interaction that
modulates phase separation. As the genome and antigenome of HMPV are fully coated
by N, P could interact with viral mRNAs or with cellular RNAs in the context of an infection. Features of viral P proteins, including long regions of intrinsic disorder, match the
molecular signature of proteins that phase separate under physiological conditions
(23, 27). Furthermore, they are consistent with HMPV P as a scaffold protein that binds
a variety of substrates, such as viral proteins and RNA, to promote IB formation. The
recently published structure of the HMPV polymerase/P protein complex highlights
the importance of IDRs in allowing HMPV P to adopt a variety of binding conformations (31, 42). The propensity for HMPV P to mediate multivalent interactions and
phase separate independently in vitro suggests that it regulates similar functions for IB
formation during infection (35).
In contrast to our in vitro results, the HMPV N and P proteins must be coexpressed
in cells to generate IB-like structures (25). Without HMPV N, the P protein showed both
diffuse cytoplasmic localization and peripheral ﬁlopodia-like localization (25). This difference between the cellular and in vitro systems suggests that host factors in the cytoplasm may block HMPV P interactions required to induce phase separation.
Coexpression of HMPV P and N likely acts to initiate phase separation in cells by concentrating enough IB components to drive phase separation. Phase separation is a
highly sensitive process that depends on factors such as protein/RNA concentration,
salt content, post-translational modiﬁcations, pH, and temperature (23). One or more
of these factors may prevent HMPV P from phase separating when expressed independently in cells. Furthermore, results showed that removal of nucleic acid from puriﬁed HMPV P modulated liquid droplet formation in vitro (Fig. 5), suggesting that HMPV
P phase separation in cells may be impacted signiﬁcantly by the presence of RNA.
Additionally, during HMPV infection, the N protein is always expressed in excess compared with HMPV P due to the location of the N gene within the viral genome. This
result suggests that HMPV P may lack opportunities for independent phase separation
during infection due the local concentration of other viral factors involved in IB formation. Although in vitro studies are crucial for deciphering the mechanisms of HMPV
phase separation, the increased complexity of protein and RNA interactions during cellular infection must always be considered.
Our work is the ﬁrst to provide evidence of a viral P protein functioning as a phaseseparation scaffold, in contrast to related systems. Recent reports on MeV and RSV
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showed that a combination of the E. coli-expressed N and P proteins were required to
induce droplet formation in vitro (20, 21), and our work also shows the absence of phase
separation when RSV P is examined in isolation (Fig. 4A). Although Mononegavirales P
proteins share common structural features, they lack sequence similarity and vary in
length (43). MeV P is 213 residues longer than HMPV P and includes a folded C-terminal
(XD) domain after the unfolded Ploop. The pneumoviral RSV and HMPV P proteins possess
a similar domain organization, but sequence differences likely promote unique phaseseparation interactions for each virus. For instance, HMPV P is 53 residues longer than
RSV P and contains insertions in the N-terminal and C-terminal domains that may inﬂuence IDR behavior (43) (Fig. 4B; see Fig. S4 in the supplemental material). The C-terminal
domain and oligomerization domain of RSV P were required for liquid droplet formation
with N-RNA, suggesting that the acidic insertion in the HMPV P C-terminal domain may
modulate phase separation (21, 43). The differences observed for these viral systems
emphasize that phase separation is highly dependent on multivalent interactions mediated by the unique composition of the P protein.
The puriﬁed P proteins studied in our work and in work on RSV P (21) and measles virus P (20) were expressed in E. coli and thus may lack post-translational modiﬁcations,
such as phosphorylation. The viral P proteins, as so named due to the presence of phosphorylation at multiple locations on the protein, and previous studies on RSV (44–46) and
Sf9-expressed HMPV P (31) indicate that pneumovirus P proteins are phosphorylated.
However, no information about the sites of phosphorylation utilized during HMPV infection is available, nor is it known if these sites change over the course of infection. Measles
virus inclusion body size was shown to be inﬂuenced by P protein phosphorylation and the
host enzyme casein kinase 2 (19), suggesting a potential link between post-translational
modiﬁcations of P and the dynamics of inclusion body formation. In addition, a number of
studies in multiple systems have found a role for phosphorylation in the control of phase
separation (19, 35, 47, 48). Thus, future experiments to determine how P protein phosphorylation modulates over the course of infection and how these post-translational modiﬁcations impact related phase separation represent an exciting direction, and they could be
paired with studies of puriﬁed proteins containing the same sets of phosphorylation sites
to assess the impact of each utilized site on phase separation dynamics.
Although HMPV N and P are required for IB formation in cells, the role of different N
protein forms in phase separation required further exploration. We compared monomeric N protein (N0-P) and N-RNA with N K171A/R186A to analyze the effects of oligomerization and RNA binding on phase separation with the HMPV P scaffold. Although
all of the N forms were recruited to droplets by HMPV P, the incorporation of N K171A/
R186A led to the formation of droplets that failed to undergo complete fusion, suggesting that they were gel-like rather than liquid-like in nature. This ﬁnding highlights
that RNA interactions with HMPV N and P alter phase-separation dynamics and suggests that viral RNA levels may modulate IB maturation during the course of HMPV
infection. A minimal MeV phase-separation in vitro system showed that RNA diffuses
into MeV N/P liquid droplets, triggering the formation of nucleocapsid-like particles
(20). Interestingly, coexpression of a MeV N RNA-binding mutant with P did not alter
the morphology of IB-like structures in cells compared to coexpression of WT N and P
(19). These ﬁndings suggest that RNA binding is not required for MeV IB formation, but
RNA incorporation likely serves to enhance ribonucleoprotein assembly during infection. In contrast, a monomeric RNA-free RSV N mutant failed to form IB-like structures
with RSV P in cells, suggesting that RSV N must oligomerize and/or bind RNA to mediate IB formation (21). Our in vitro results with HMPV N0-P and N K171A/R186A conﬁrmed that N protein oligomerization and RNA interactions are not required for phase
separation with HMPV P.
Here, we showed that HMPV IBs are liquid organelles and that HMPV P acts as a
scaffold to recruit different forms of N to liquid droplets. We report that nucleic acid
interactions with P and N alter phase-separation dynamics, suggesting that viral RNA
binding plays a signiﬁcant role in HMPV IB formation and maturation. Recent work on
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RSV utilized a condensate-hardening drug to block RSV replication in the lungs of
infected mice (49). This exciting evidence suggests that IBs of various negative-strand
viruses may serve as druggable targets for inhibiting infection. The work presented
here builds on the foundation for understanding the formation of IBs and the mechanisms that regulate phase separation for negative-strand viruses. Deciphering the protein and RNA interactions that inﬂuence IB phase separation will be essential for the
development of pan-antiviral drugs to target viral factories.

Construction of a recombinant HMPV-mCherryP virus. The plasmids encoding the full-length genome sequence of HMPV strain JPS02-76 (p1JPS07E2) and the accessory proteins N, M2-1, L, and P
(pCITE-76N, -76M2-1, -76L, and -76P) were kindly provided by Makoto Takeda (National Institute of
Infectious Diseases, Tokyo, Japan) (34). To insert the mCherryP cassette within the p1JPS07E2 plasmid, a
vector containing the partial sequence of N followed by the N terminus mCherry-tagged P sequence,
ﬂanked by NheI and SacI restriction sites, was synthesized (GenScript). The sequence within this vector
was then subcloned into p1JPS07E2 using the NheI and SacI restriction sites. The correct insertion of
the cassette into the plasmid was veriﬁed by sequencing. To rescue the recombinant HMPV, the methodology described by Shirogane et al. (34) was used. Brieﬂy, BSR cells stably expressing the T7 RNA polymerase were transfected with plasmids p1JPS07E2 and pCITE-76N, -76M2-1, -76L, and -76P using
Lipofectamine3000, following manufacturer instructions. Forty-eight hours posttransfection, the cells
were scraped from the plate onto the medium, and half of the volume was overlaid onto a monolayer of
Vero cells, in Opti-MEM with 0.3 m g/mL tosylsulfonyl phenylalanyl chloromethyl ketone-trypsin (TPCKTry). The medium was replaced every other day until extensive cytopathic effect and ﬂuorescent signal
were observed. Cells and media were then recovered and used to propagate the passage 1 of the
recombinant virus in Vero cells, as described previously.
Fluorescence recovery after photobleaching (FRAP). Vero cells were transfected with a pCAGGS
plasmid expressing mCherry-P only (P) or cotransfected with pCAGGS plasmids encoding mCherry-P
and N protein (P1N). Twenty-four hours post-transfection, live-cell confocal microscopy was used to perform FRAP at 37°C on punctate regions by drawing a region of interest (ROI) representing a whole inclusion body or an equivalent area in the cytosol with the P protein only. Imaging was completed on the
Nikon A1R confocal microscope, using a Plan Fluor 40 oil DIC objective. For photobleaching, a laser
wavelength of 405 nm with a laser power setting of 100% was utilized. Each experiment used 5 s of prebleaching acquisition, with 4 to 5 min of recovery.
Expression and puriﬁcation of HMPV P. The CAN97-83 HMPV P construct was cloned into the plasmid pET 302/NT-His between the cleavage sites EcoRI and XhoI and expressed in BL21(DE3) CodonPlus RIL
cells (Agilent) overnight at 37°C in terriﬁc broth (TB) containing ampicillin after induction at an optical density (OD) of 1.4 with 1 mM isopropyl- b -D-thiogalactopyranoside (IPTG). Cells were lysed with 20 mM Tris and
200 mM NaCl (pH 7.5) containing cOmplete EDTA-free protease inhibitor cocktail (Sigma) and 125 m g/mL lysozyme. After cells were incubated on ice for 20 min, the solution was sonicated three times at 60% intensity
for 15 sec. The lysate was spun at 18,000 rpm for 30 min at 4°C. The crude lysate rocked with His-select
nickel afﬁnity gel resin (Sigma) for 45 min at 4°C. The resin was washed one time with lysis buffer and
two times with 20 mM Tris, 200 mM NaCl, and 20 mM imidazole (pH 7.5). The protein was eluted with
20 mM Tris, 200 mM NaCl, and 250 mM imidazole (pH 7.5). The eluate was loaded onto a HiTrap Q
high-performance (HP) anion-exchange chromatography column (Cytiva). The column was washed
with 20 mM Tris (pH 7.5). Then, fractions were eluted with 20 mM Tris and 1 M NaCl (pH 7.5). The fractions containing HMPV P were concentrated, and buffer was exchanged into 25 mM HEPES and
150 mM KCl (pH 7.5) using a PD-10 desalting column with Sephadex G-25 resin (GE Healthcare).
To reduce nucleic acid binding, some HMPV P lysates were treated with Benzonase during the cell
lysis step. Instead of anion exchange, the His-select puriﬁcation was followed by heparin puriﬁcation
using a HiTrap heparin HP column with an increasing NaCl gradient from 200 mM to 1 M prior to buffer
exchange with the PD-10 column. After buffer exchange, the protein was concentrated, ﬂash frozen, and
stored at 280°C. Protein purity was then examined via PAGE (see Fig. S2 in the supplemental material).
Expression and puriﬁcation of HMPV N0-P. The CAN97-83 HMPV N0-P construct with a 6 C-terminal
His6 tag was synthesized by GenScript in the pET-29b(1) plasmid and cloned between the NdeI and KpnI
cleavage sites. The construct was expressed in E. coli Rosetta 2(DE3) competent cells (Novagen) overnight
at 18°C in TB containing kanamycin after induction at an OD of 0.8 with IPTG. Cells were lysed (20 mM Tris,
500 mM NaCl, 10 mM imidazole [pH 7], protease inhibitor, lysozyme, and 250 units of benzonase [Sigma])
and incubated on ice for 20 min. The solution was sonicated and spun as described above except the lysate
spun for 45 min. The crude lysate was incubated with resin as described above. The resin was washed once
with 20 mM Tris, 500 mM NaCl, and 10 mM imidazole [pH 7] and twice with 20 mM Tris and 500 mM NaCl
[pH 7]; and the protein was eluted with 20 mM Tris, 500 mM NaCl, and 300 mM imidazole (pH 7). The eluate
was concentrated and buffer exchanged into 25 mM HEPES and 150 mM KCl (pH 7.5). The protein was concentrated and stored as described above. Protein purity was determined via PAGE (Fig. S2).
Expression and puriﬁcation of HMPV N-RNA. The CAN97-83 HMPV N construct with a 6 C-terminal
His6 tag was synthesized and cloned into pET-29b(1) as described above. The construct was expressed and
induced as described for N0-P. Cells were lysed (25 mM Tris, 1 M NaCl [pH 8], protease inhibitor, lysozyme,
and Benzonase) and treated as described above except the lysate spun for 1 h. The crude lysate was loaded
onto a column containing preequilibrated resin at 4°C, washed two times (25 mM Tris and 1 M NaCl [pH 8]),
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and eluted (25 mM Tris, 1 M NaCl, and 400 mM imidazole [pH 8]). The eluate was concentrated, and the
NaCl concentration of the sample was adjusted to 100 mM using 25 mM Tris (pH 8). Then, the sample was
loaded onto a HiTrap heparin HP column (Sigma) using an increasing NaCl gradient from 200 mM to 1 M.
Fractions containing the HMPV N protein were buffer exchanged and stored as described above. Protein
quality was veriﬁed via PAGE (Fig. S2).
Expression and puriﬁcation of HMPV N K171A/R186A. The CAN97-83 HMPV N mutant was generated using QuikChange site-directed mutagenesis in pUC57 and subcloned into pET29b(1) using BamHI
and XbaI cleavage sites. The construct was expressed, induced, lysed, and spun as described for N0-P.
The crude lysate was loaded onto a column containing resin as described for N-RNA, and the resin was
washed once with 20 mM Tris, 500 mM NaCl, and 10 mM imidazole (pH 7) and once with 20 mM Tris
and 500 mM NaCl (pH 7). The protein was eluted with 20 mM Tris, 500 mM NaCl, and 300 mM imidazole
(pH 7). The eluate was concentrated, and the NaCl concentration of the sample was adjusted to 100 mM
using 20 mM Tris (pH 7). Then, the sample was heparin puriﬁed as described for N-RNA. Fractions were
buffer exchanged and stored as described above. Protein quality was veriﬁed via PAGE (Fig. S2).
Expression and puriﬁcation of RSV A2 P. RSV A2 P constructs were expressed as MBP-His tag
fusion proteins in BL21(DE3) E. coli cells (Novagen) using a modiﬁed pET15b vector. At an optical density
at 600 nm (OD600) of 0.6 to 0.7, recombinant protein expression was induced with 0.5 mM isopropylb -D-1-thiogalactopyranoside (IPTG) for 12 to 14 h at 18°C. Cells were harvested and resuspended in lysis
buffer containing 20 mM Tris (pH 7.5), 150 mM NaCl, 20 mM imidazole, and 5 mM 2-mecaptoethanol
(BME) with protease inhibitors. Cells were lysed using an EmulsiFlex-C5 homogenizer (Avestin), and
lysates were clariﬁed by centrifugation at 30,000  g at 4°C for 40 min. P proteins were puriﬁed sequentially using afﬁnity tag columns (Ni and amylose), ion exchange Q column, and gel ﬁltration column
(10 mM HEPES, 150 mM NaCl, and 2 mM tris(2-carboxyethyl)phosphine hydrochloride [TCEP]). Fractions
were pooled and concentrated and then aliquoted and ﬂash frozen in liquid nitrogen. The purity of P
proteins was determined by Coomassie staining of SDS-PAGE. The MBP-His tag was removed by the TEV
protease (TEV) protease. To conﬁrm protein quality, at the time of droplet assays, a side-by-side PAGE
was run with HMPV P (anion) and RSV P (Fig. S2).
Protein labeling. Prior to buffer exchange, puriﬁed HMPV N0-P was labeled with Alexa 488 TFP ester
(ThermoFisher). The Alexa 488 tetraﬂuorophenyl (TFP) ester was prepared with DMSO to make a 10-mg/
mL solution. The solution was added dropwise to the protein sample. The sample rocked for 1 h in the
dark and was buffer exchanged and stored as described above. Anion exchange-puriﬁed HMPV P was labeled in a similar manner using the Alexa 594 N-hydroxysuccinimide (NHS) ester (ThermoFisher).
Droplet assay. A 20% dextran solution was prepared in 25 mM HEPES and 150 mM KCl (protein storage buffer; pH 7.5). Dithiothreitol (DTT) was added to the dextran solution to give a ﬁnal concentration
of 1 mM. HMPV protein constructs were diluted in the 20% dextran, 1 mM DTT, 25 mM HEPES, and
150 mM KCl (pH 7.5) solution in 1.5-mL Eppendorf tubes. This solution was used in samples for standard
droplet imaging, fusion droplet imaging, and turbidity assays. For the HMPV P samples tested at different KCl concentrations, similar buffers were prepared with KCl ranging from 0 mM to 500 mM. A total of
1.5 m L of sample was placed on an 8-well printed microscopy slide and covered with a glass coverslip.
For droplets imaged at later time points, the slides were stored in a humidiﬁed chamber.
Droplet microscopy imaging. HMPV puriﬁed protein samples were imaged using either DIC or epiﬂuorescence on a Nikon Eclipse E600 instrument with the 60 objective or on an Axiovert 200M instrument with a 100 oil objective. Fusion time lapse images were acquired with MetaMorph software using
DIC on a Zeiss Axiovert 200M microscope with the 100 oil objective. Images were acquired at 0.3-sec
or 0.5-sec intervals.
RNA oligomer. The ﬂuorescent RNA decamer was purchased from Integrated DNA Technologies. It
was terminated with OH at the 59 end and 6-carboxyﬂuorescein at the 39 end.
Turbidity assay. Protein solutions were mixed with 20% dextran, 1 mM DTT, 25 mM HEPES, and
150 mM KCl (pH 7.5) in clear 96-well plates. The ﬁnal concentration of the protein was 40 m M. The absorbance of the solutions was measured on a SpectraMax iD3 instrument at 395 nm (20). Readings were
taken at 5-min intervals for 8 h or longer.
Live-cell imaging. VeroE6 cells were seeded in 12-well glass-bottom culture plates and the day after
were infected with HMPV-mCherryP using an MOI of 3. Cells were kept at 37°C in a 5% CO2 atmosphere
until imaging. Images were acquired in a LionHeartFX ﬂuorescence microscope using a 60 oil immersion objective. At 24, 48, and 72 hpi, infected cultures were imaged for 10 min, with images taken every
30 s. At least 5 different infected cells were imaged per condition. Alternatively, Vero cells were electroporated with 100 ng of a plasmid encoding mCherryP using a Neon system (ThermoFisher), pulsed at
220V and 950 m F, and subsequently seeded in 6-well glass bottom culture plates. Twenty-four hours
postelectroporation, cells were infected with rgHMPV at an MOI of 3 and kept for another 48 h at 37°C
in a 5% CO2 atmosphere. Cells were imaged in a NikonA1 confocal microscope, acquiring images every
25 s using the 60 oil immersion objective.

SUPPLEMENTAL MATERIAL
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FIG S1, TIF ﬁle, 2.5 MB.
FIG S2, TIF ﬁle, 2.6 MB.
FIG S3, TIF ﬁle, 2.8 MB.
FIG S4, TIF ﬁle, 1.1 MB.
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